Is COVID-19 Seasonal?

While the weather isn’t currently the dominant factor driving SARS-CoV-2 transmission, experts say that in the future COVID-19 may become a disease of winter.

Written byAlejandra Manjarrez, PhD
| 7 min read
illustration of blue coronavirus particles with snowflakes in the background
Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Early in the pandemic, some believed that the arrival of summer would make COVID-19 cases drop, much like the flu. In March 2020, Brazil’s president Jair Bolsonaro implied that his country should not expect a COVID-19 crisis like that in Italy at the time, given the “totally different” climates of the two places. “Maybe this goes away with heat and light,” said then–US President Donald Trump the following month.

But the increased number of cases in the US and other countries in the Northern Hemisphere in the summer of 2020 contradicted these predictions. Moreover, the tropics were not spared from high death tolls, despite their lack of wintry weather. Brazil and India emerged, for instance, as two of the leading pandemic hotspots.

These events illustrate that climate has not governed whether COVID-19 emerges or vanishes in a given place or time. But nearly two years after the first reported cases, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • alejandra manjarrez

    Alejandra Manjarrez is a freelance science journalist who contributes to The Scientist. She has a PhD in systems biology from ETH Zurich and a master’s in molecular biology from Utrecht University. After years studying bacteria in a lab, she now spends most of her days reading, writing, and hunting science stories, either while traveling or visiting random libraries around the world. Her work has also appeared in Hakai, The Atlantic, and Lab Times.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies